Evidence map›Paper›PMID 31556460›Full record

ArticleThe EMBO journal2019

Translational offsetting as a mode of estrogen receptor α-dependent regulation of gene expression.

Julie Lorent, Eric P Kusnadi, Vincent van Hoef, Richard J Rebello, Matthew Leibovitch, Johannes Ristau, Shan Chen, Mitchell G Lawrence, Krzysztof J Szkop, Baila Samreen and 13 more

Open access · bronzeAbstract read
In one paragraph

Article in The EMBO journal, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. CXXC5 is a ubiquitinated protein and is degraded by the ubiquitin-proteasome pathway.Protein science : a publication of the Protein Society · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Polysome Fractionation for Transcriptome-Wide Studies of mRNA Translation.Methods in molecular biology (Clifton, N.J.) · 2022
    Article
  16. Anota2seq Analysis for Transcriptome-Wide Studies of mRNA Translation.Methods in molecular biology (Clifton, N.J.) · 2022
    Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

23 authors at 10 institutions in 7 countries.

Julie LorentScience for Life Laboratory, Department of Oncology-Pathology, Karolinska Institutet, Solna, Sweden.
Eric P KusnadiProstate Cancer Translational Research Laboratory, Peter MacCallum Cancer Centre, Melbourne, Vic., Australia.
Vincent van HoefScience for Life Laboratory, Department of Oncology-Pathology, Karolinska Institutet, Solna, Sweden.
Richard J RebelloProstate Cancer Translational Research Laboratory, Peter MacCallum Cancer Centre, Melbourne, Vic., Australia.
Matthew LeibovitchGerald Bronfman Department of Oncology and Departments of Biochemistry and Experimental Medicine, Lady Davis Institute, McGill University, Montreal, QC, Canada.
Johannes RistauScience for Life Laboratory, Department of Oncology-Pathology, Karolinska Institutet, Solna, Sweden.
Shan ChenScience for Life Laboratory, Department of Oncology-Pathology, Karolinska Institutet, Solna, Sweden.
Mitchell G LawrenceProstate Cancer Translational Research Laboratory, Peter MacCallum Cancer Centre, Melbourne, Vic., Australia.
Krzysztof J SzkopScience for Life Laboratory, Department of Oncology-Pathology, Karolinska Institutet, Solna, Sweden.
Baila SamreenScience for Life Laboratory, Department of Oncology-Pathology, Karolinska Institutet, Solna, Sweden.
Preetika BalanathanCancer Program, Biomedicine Discovery Institute and Department of Anatomy and Developmental Biology, Monash University, Clayton, Vic., Australia.
Francesca RapinoLaboratory of Cancer Signaling, GIGA-Institute, University of Liège, Liège, Belgium.
Pierre CloseLaboratory of Cancer Signaling, GIGA-Institute, University of Liège, Liège, Belgium.
Patricia BukczynskaProstate Cancer Translational Research Laboratory, Peter MacCallum Cancer Centre, Melbourne, Vic., Australia.
Karin ScharmannMax Planck Institute for Molecular Biomedicine, Münster, Germany.
Itsuhiro TakizawaCancer Program, Biomedicine Discovery Institute and Department of Anatomy and Developmental Biology, Monash University, Clayton, Vic., Australia.
Gail P RisbridgerProstate Cancer Translational Research Laboratory, Peter MacCallum Cancer Centre, Melbourne, Vic., Australia.
Luke A SelthDame Roma Mitchell Cancer Research Laboratories and Freemasons Foundation Centre for Men's Health, Adelaide Medical School, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, SA, Australia.
Sebastian A LeidelMax Planck Institute for Molecular Biomedicine, Münster, Germany.ORCID 0000-0002-0523-6325
Qishan LinRNA Epitranscriptomics & Proteomics Resource, Department of Chemistry, University at Albany, Albany, NY, USA.
Ivan TopisirovicGerald Bronfman Department of Oncology and Departments of Biochemistry and Experimental Medicine, Lady Davis Institute, McGill University, Montreal, QC, Canada.ORCID 0000-0002-5510-9762
Ola LarssonScience for Life Laboratory, Department of Oncology-Pathology, Karolinska Institutet, Solna, Sweden.ORCID 0000-0003-1412-1308
Luc FuricProstate Cancer Translational Research Laboratory, Peter MacCallum Cancer Centre, Melbourne, Vic., Australia.ORCID 0000-0002-1893-9812
Science for Life Laboratory · SEThe University of Melbourne · AUAustralian Regenerative Medicine Institute · AUMcGill University · CAPeter MacCallum Cancer Centre · AUUniversity of Liège · BEFreemasons Foundation Centre for Men's Health · AUUniversity at Albany, State University of New York · USUniversity of Bern · CHUniversity of Münster · DE

Funding

Control of Protein Synthesis by the UPS Under StressR01CA202021 · NCI · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI RONAI, ZEEV A. · 2016 to 2020
$2.3M
Cancerfonden (Swedish Cancer Society) 2016/526Cancerföreningen i Stockholm (Cancer Society in Stockholm) 151153Department of Health and Human Services, State Government of Victoria (DHHS) MCRF16007Department of Health and Human Services, State Government of Victoria (DHHS) MCRF18017Department of Health | National Health and Medical Research Council (NHMRC) APP1102752Department of Health | National Health and Medical Research Council (NHMRC) APP1141339Department of Health | National Health and Medical Research Council (NHMRC) APP1145777Deutsche Forschungsgemeinschaft (DFG) LE 3260/3-1EJ Whitten FoundationFonds de Recherche du Québec-Santé (FRQS) 34872Gouvernement du Canada | Canadian Institutes of Health Research (CIHR) MOP-363027HHS | National Institutes of Health (NIH) R01 CA 202021-01-A1Knut och Alice Wallenbergs Stiftelse (Knut and Alice Wallenberg Foundation) 2013.0181NCI NIH HHS R01 CA202021STRATCANSwedish Foundation for International Cooperation in Research and Higher Education (STINT) IG2012-2073Vetenskapsrådet (VR) 2016-02891Walloon Excellence in Life Sciences and Biotechnology (WELBIO)
6 · The paper itself

Abstract

Estrogen receptor alpha (ERα) activity is associated with increased cancer cell proliferation. Studies aiming to understand the impact of ERα on cancer-associated phenotypes have largely been limited to its transcriptional activity. Herein, we demonstrate that ERα coordinates its transcriptional output with selective modulation of mRNA translation. Importantly, translational perturbations caused by depletion of ERα largely manifest as "translational offsetting" of the transcriptome, whereby amounts of translated mRNAs and corresponding protein levels are maintained constant despite changes in mRNA abundance. Transcripts whose levels, but not polysome association, are reduced following ERα depletion lack features which limit translation efficiency including structured 5'UTRs and miRNA target sites. In contrast, mRNAs induced upon ERα depletion whose polysome association remains unaltered are enriched in codons requiring U34-modified tRNAs for efficient decoding. Consistently, ERα regulates levels of U34-modifying enzymes and thereby controls levels of U34-modified tRNAs. These findings unravel a hitherto unprecedented mechanism of ERα-dependent orchestration of transcriptional and translational programs that may be a pervasive mechanism of proteome maintenance in hormone-dependent cancers.

Indexed as

Gene Expression Regulation, NeoplasticProtein BiosynthesisBreast NeoplasmsCell ProliferationEstrogen Receptor alphaFemaleHumansMCF-7 CellsPolyribosomesRNA, MessengerSignal TransductionTranscriptional ActivationESR1 protein, humanEstrogen Receptor alphaRNA, Messenger5′ UTRestrogen receptorhormone-dependent cancermRNA translationU34 tRNA modification

Identifiers

PMID31556460
PMCPMC6885737
OpenAlexW2975051965

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.